Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Br J Radiol

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    March 2017
  1. YU J, Fulcher AS, Winks SG, Turner MA, et al
    Diagnosis of Typical and Atypical Transitional Zone Prostate Cancer and its Mimics at Multiparametric Prostate MRI.
    Br J Radiol. 2017 Mar 3:20160693. doi: 10.1259/bjr.20160693.
    PubMed     Text format     Abstract available


    February 2017
  2. NITSCHE M, Brannath W, Bruckner M, Wagner D, et al
    Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Br J Radiol. 2017;90:20160370.
    PubMed     Text format     Abstract available


    January 2017
  3. HARVEY H, Orton MR, Morgan VA, Parker C, et al
    Volumetry of the Dominant Intraprostatic Tumour Lesion: Intersequence and Interobserver Differences on Multiparametric MRI.
    Br J Radiol. 2017 Jan 5:20160416. doi: 10.1259/bjr.20160416.
    PubMed     Text format     Abstract available


    December 2016
  4. CHAN J, Carver A, Brunt JN, Vinjamuri S, et al
    Effect of androgen deprivation therapy on intra-prostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.
    Br J Radiol. 2016 Dec 20:20160818.
    PubMed     Text format     Abstract available


  5. ARIYARATNE H, Chesham H, Alonzi R
    Image-guided radiotherapy for prostate cancer in the United Kingdom: a national survey.
    Br J Radiol. 2016 Dec 7:20160059.
    PubMed     Text format     Abstract available


  6. O'NEILL AG, Jain S, Hounsell AR, O'Sullivan JM, et al
    Fiducial marker guided prostate radiotherapy: a review.
    Br J Radiol. 2016;89:20160296.
    PubMed     Text format     Abstract available


    October 2016
  7. KATARIA T, Gupta D, Goyal S, Bisht SS, et al
    Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: An MRI based approach.
    Br J Radiol. 2016 Oct 17:20160348.
    PubMed     Text format     Abstract available


  8. ALMATANI T, Hugtenburg RP, Lewis RD, Barley SE, et al
    Automated algorithm for CBCT-based dose calculations of prostate radiotherapy with bilateral hip prostheses.
    Br J Radiol. 2016;89:20160443.
    PubMed     Text format     Abstract available


    July 2016
  9. FELLIN G, Mirri MA, Santoro L, Jereczek-Fossa BA, et al
    Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: Practice and outcome analysis in a series of 2237 patients from 11 Institutions.
    Br J Radiol. 2016 Jul 7:20150981.
    PubMed     Text format     Abstract available


  10. YARTSEV S, Bauman G
    Target margins in radiotherapy of prostate cancer.
    Br J Radiol. 2016 Jul 5:20160312.
    PubMed     Text format     Abstract available


  11. JERECZEK-FOSSA BA, Ciardo D, Ferrario S, Fossati P, et al
    No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy.
    Br J Radiol. 2016;89:20150985.
    PubMed     Text format     Abstract available


    May 2016
  12. VAN HOLSBEECK A, Degroote A, De Wever L, Vanhoutte E, et al
    Staging of prostatic carcinoma at 1.5 T MRI: correlation of a simplified MRI exam with whole mount radical prostatectomy specimens.
    Br J Radiol. 2016 May 16:20160101.
    PubMed     Text format     Abstract available



  13. Correction to MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.
    Br J Radiol. 2016;89:11253478c.
    PubMed     Text format    


    April 2016
  14. WU LM, Zhao ZZ, Chen XX, Lu Q, et al
    Comparison of T2* Mapping with Diffusion-Weighted Imaging in the Characterization of Low- vs Intermediate- and High-Grade Prostate Cancer.
    Br J Radiol. 2016 Apr 19:20151076.
    PubMed     Text format     Abstract available


    March 2016
  15. LIN WC, Muglia VF, Silva GE, Chodraui Filho S, et al
    Multiparametric Magnetic Resonance Imaging of the Prostate: Diagnostic Performance and Inter-reader Agreement of Two Scoring Systems.
    Br J Radiol. 2016 Mar 23:20151056.
    PubMed     Text format     Abstract available


  16. ISHII K, Ogino R, Hosokawa Y, Fujioka C, et al
    Comparison of dosimetric parameters and acute toxicity after whole-pelvic versus prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.
    Br J Radiol. 2016 Mar 9:20150930.
    PubMed     Text format     Abstract available


    February 2016
  17. BOONSTRA PS, Taylor JM, Smolska-Ciszewska B, Behrendt K, et al
    Alpha/beta (alpha/beta) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost.
    Br J Radiol. 2016 Feb 23:20150957.
    PubMed     Text format     Abstract available


    January 2016
  18. WONG WK, Leung LH, Kwong DL
    Evaluation and optimization of the parameters used in multiple-atlas-based segmentation of prostate cancers in radiation therapy.
    Br J Radiol. 2016;89:20140732.
    PubMed     Text format     Abstract available


  19. THOMAS SJ, Romanchikova M, Harrison K, Parker MA, et al
    Recalculation of dose for each fraction of treatment on TomoTherapy.
    Br J Radiol. 2016;89:20150770.
    PubMed     Text format     Abstract available


  20. DANISH QASEEM SM, Ghonge NP, Aggarwal B, Singhal S, et al
    Prospective evaluation of prostate with transrectal spectral Doppler with biopsy correlation: a clinicopathologic study.
    Br J Radiol. 2016;89:20150830.
    PubMed     Text format     Abstract available


    December 2015
  21. LANGMACK KA, Newton LA, Jordan S, Smith R, et al
    Cone-beam CT Dose Reduction in Prostate Radiotherapy using Likert Scale Methods.
    Br J Radiol. 2015 Dec 21:20150460.
    PubMed     Text format     Abstract available


  22. PARK SY, Kim CK, Park JJ, Park BK, et al
    Exponential apparent diffusion coefficient in evaluating prostate cancer at 3T: preliminary experience.
    Br J Radiol. 2015 Dec 10:20150470.
    PubMed     Text format     Abstract available


  23. WAHART A, Guy JB, Vallard A, Geissler B, et al
    Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-Choline for guiding target volume delineation.
    Br J Radiol. 2015 Dec 9:20150579.
    PubMed     Text format     Abstract available


    November 2015
  24. LAVAN N, Kavanagh DO, Martin J, Small C, et al
    The curative management of synchronous rectal and prostate cancer.
    Br J Radiol. 2015 Nov 5:20150292.
    PubMed     Text format     Abstract available


    October 2015
  25. KISHAN AU, Park SJ, King CR, Roberts K, et al
    Dosimetric Benefits of Hemi-Gland Stereotactic Body Radiotherapy for Prostate Cancer: Implications for Focal Therapy.
    Br J Radiol. 2015 Oct 14:20150658.
    PubMed     Text format     Abstract available


  26. FALCINELLI L, Palumbo I, Radicchia V, Arcidiacono F, et al
    Prostate cancer: contouring target and organs at risk by kilo- and mega-voltage computed tomography and magnetic resonance imaging in patients with and without hip prostheses.
    Br J Radiol. 2015 Oct 14:20150509.
    PubMed     Text format     Abstract available


    August 2015
  27. LIM C, Malone S, Avruch L, Breau R, et al
    Magnetic Resonance for radiotherapy management and treatment planning in prostatic carcinoma.
    Br J Radiol. 2015 Aug 17:20150507.
    PubMed     Text format     Abstract available


  28. NOTLEY M, Yu J, Fulcher AS, Turner MA, et al
    Diagnosis of Recurrent Prostate Cancer and Its Mimics at Multiparametric Prostate MRI.
    Br J Radiol. 2015 Aug 13:20150362.
    PubMed     Text format     Abstract available


  29. HAUTH E, Hohmuth H, Cozub-Poetica C, Bernand S, et al
    Multiparametric MRI of prostate with three functional techniques in patients with PSA-elevation before initial TRUS-guided biopsy.
    Br J Radiol. 2015 Aug 13:20150422.
    PubMed     Text format     Abstract available


  30. HAMLETT LJ, McPartlin A, Maile E, Webster G, et al
    Parametrised rectal dose and associations with late-toxicity in prostate cancer radiotherapy.
    Br J Radiol. 2015 Aug 6:20150110.
    PubMed     Text format     Abstract available


  31. MCNAIR HA, Harris EJ, Hansen VN, Thomas K, et al
    Magnitude of observer error using cone beam CT for prostate inter-fraction motion estimation: effect of reducing scan length or increasing exposure.
    Br J Radiol. 2015 Aug 6:20150208.
    PubMed     Text format     Abstract available


  32. RUGGIERI R, Naccarato S, Stavrev P, Stavreva N, et al
    Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
    Br J Radiol. 2015 Aug 3:20140736.
    PubMed     Text format     Abstract available


    July 2015
  33. SCAIFE JE, Thomas SJ, Harrison K, Romanchikova M, et al
    Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer.
    Br J Radiol. 2015 Jul 24:20150243.
    PubMed     Text format     Abstract available


  34. MORI S, Inaniwa T, Miki K, Tanimoto K, et al
    Variation in patient position and impact on carbon-ion scanning beam distribution during prostate treatment.
    Br J Radiol. 2015;88:20140623.
    PubMed     Text format     Abstract available


    June 2015
  35. ZERINI D, Jereczek-Fossa BA, Fodor C, Bazzani F, et al
    Salvage Image Guided Intensity Modulated or Stereotactic Body re-irradiation of local recurrence of prostate cancer.
    Br J Radiol. 2015 Jun 9:20150197.
    PubMed     Text format     Abstract available


  36. COULTER JA, Butterworth KT, Jain S
    Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.
    Br J Radiol. 2015 Jun 8:20150256.
    PubMed     Text format     Abstract available


  37. JANG H, Baek JG, Yoo SJ
    Acute anal toxicity after whole pelvic radiotherapy in patients with asymptomatic haemorrhoids: identification of dosimetric and patient factors.
    Br J Radiol. 2015;88:20150022.
    PubMed     Text format     Abstract available


    May 2015
  38. PARK JM, Wu HG, Kim JH, Carlson JN, et al
    The effect of MLC speed and acceleration on the plan delivery accuracy of VMAT.
    Br J Radiol. 2015;88:20140698.
    PubMed     Text format     Abstract available


    March 2015
  39. LINEY GP, Holloway L, Al Harthi TM, Sidhom M, et al
    Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate.
    Br J Radiol. 2015 Mar 5:20150034.
    PubMed     Text format     Abstract available


    January 2015
  40. LUPATTELLI M, Alcusky M, Aristei C, Bellavita R, et al
    Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists.
    Br J Radiol. 2015;88:20150587.
    PubMed     Text format     Abstract available


  41. MANCOSU P, Reggiori G, Gaudino A, Lobefalo F, et al
    Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions.
    Br J Radiol. 2015;88:20150468.
    PubMed     Text format     Abstract available


  42. HEIKKILA VP
    PEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluation.
    Br J Radiol. 2015;88:20150421.
    PubMed     Text format     Abstract available


  43. DASU A, Toma-Dasu I
    Will intrafraction repair have negative consequences on extreme hypofractionation in prostate radiation therapy?
    Br J Radiol. 2015;88:20150588.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: